Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Employee Stock Ownership Plan (ESOP)

The following table presents the amount of compensation expense associated with the ESOP and the amount of the loan payments made by the ESOP, including the portions related to principal and interest, for the periods indicated:

	Year Ended December 31,
	2024		2023		2022
	(In thousands)
Compensation expense	$	7,356	$	7,129	$	9,923
Annual loan payment:
Interest	11,543		9,374		4,724
Principal	1,523		2,914		3,147
Total loan payment	$	13,066	$	12,288	$	7,871

The following table presents share information held by the ESOP:

	As of December 31,
	2024		2023
	(Dollars in thousands)
Allocated shares	1,889,114		1,541,971
Shares committed to be released	103,078		103,230
Unallocated shares (suspense shares)	12,784,387		13,270,932
Total shares	14,776,579		14,916,133
Fair value of unallocated shares	$	220,531	$	188,447

Schedule of Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity

The following table summarizes the Company’s restricted stock award activity for the periods indicated:

	For the Years Ended December 31,
	2024			2023
Restricted Stock Awards	Number of Shares	Weighted-Average Grant Price Per Share		Number of Shares	Weighted-Average Grant Price Per Share
Non-vested restricted stock at beginning of year	420,400	$	19.15	525,460	$	20.08
Granted	56,352	13.84		47,820	11.50
Vested	(275,474)	16.27		(152,880)	19.95
Forfeited	(3,026)	14.87		—	—
Converted in connection with merger	118,693	14.87		—	—
Non-vested restricted stock at end of year (1)	316,945	$	18.02	420,400	$	19.15

(1)Includes the effect of modifications to previously awarded and unvested restricted share awards for two plan participants to accelerate vesting. The financial effect of the modifications on total unrecognized compensation expense was not significant.

The following table summarizes the Company’s restricted stock unit activity for the periods indicated:

	For the Years Ended December 31,
	2024			2023
Restricted Stock Units	Number of Shares	Weighted-Average Grant Price Per Share		Number of Shares	Weighted-Average Grant Price Per Share
Non-vested restricted stock at beginning of year	952,001	$	19.46	972,325	$	21.08
Granted	562,454	13.83		318,577	15.63
Vested	(372,179)	18.62		(302,908)	21.08
Forfeited	(22,520)	13.20		(35,993)	15.73
Converted in connection with merger	236,766	14.87		—	—
Non-vested restricted stock at end of year (1)	1,356,522	$	16.55	952,001	$	19.46

(1)Includes the effect of modifications to previously awarded and unvested restricted share awards for one plan participant to accelerate vesting. The financial effect of the modifications on total unrecognized compensation expense was not significant.

The following table summarizes the Company’s performance stock unit activity for the periods indicated:

	For the Years Ended December 31,
	2024			2023
Performance Stock Units	Number of Shares	Weighted-Average Grant Price Per Share		Number of Shares	Weighted-Average Grant Price Per Share
Non-vested restricted stock at beginning of year	633,034	$	19.40	533,676	$	21.12
Granted	301,441	10.82		108,984	10.16
Vested	(76,353)	14.87		—	—
Forfeited	—	—		(9,626)	10.16
Converted in connection with merger	111,617	14.87		—	—
Non-vested restricted stock at end of year	969,739	$	16.63	633,034	$	19.40

Schedule of Share-based Compensation Expense Under the 2021 Plan and the Related Tax Benefit

The following table shows share-based compensation expense under the 2021 Plan and the related tax benefit for the periods indicated:

	For the Years Ended December 31,
	2024		2023		2022
	(In millions)
Share-based compensation expense	$	19.3	$	16.5	$	10.5
Related tax benefit (1)	5.3		4.7		3.0

(1)Estimated based upon the Company’s statutory rate for the respective period.